An uncertainty and sensitivity analysis applied to the prioritisation of pharmaceuticals as surface water contaminants from wastewater treatment plant direct emissions.
暂无分享,去创建一个
Xavier Gabarrell | Cristina Delerue-Matos | X. Gabarrell | S. Morais | C. Delerue-Matos | Sérgio Alberto Morais
[1] K. Fent,et al. Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.
[2] C. Delerue-Matos,et al. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. , 2010, Journal of hazardous materials.
[3] Adriano Joss,et al. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. , 2009, Water research.
[4] Thomas Knacker,et al. Targeting the environmental risk assessment of pharmaceuticals: Facts and fantasies , 2010, Integrated environmental assessment and management.
[5] F. Omil,et al. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants. , 2005, Water science and technology : a journal of the International Association on Water Pollution Research.
[6] T. E. Doll,et al. Fate of pharmaceuticals--photodegradation by simulated solar UV-light. , 2003, Chemosphere.
[7] M. Rubino,et al. Degradation of lansoprazole and omeprazole in the aquatic environment. , 2006, Chemosphere.
[8] Mark A. J. Huijbregts,et al. Uncertainty in msPAF-Based Ecotoxicological Effect Factors for Freshwater Ecosystems in Life Cycle Impact Assessment , 2007, Integrated environmental assessment and management.
[9] N Kreuzinger,et al. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[10] Hans Sanderson,et al. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. , 2004, Regulatory toxicology and pharmacology : RTP.
[11] T. Ternes. Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .
[12] M. Richter,et al. Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. , 2006, Environmental science & technology.
[13] Roberta Curini,et al. Monitoring Natural and Synthetic Estrogens at Activated Sludge Sewage Treatment Plants and in a Receiving River Water , 2000 .
[14] S. Canonica,et al. Phototransfomation of ticlosan in surface waters: a relevant elimination process for this widely used biocide--laboratory studies, field measurements, and modeling. , 2002, Environmental science & technology.
[15] B. Chefetz,et al. Combined effects of biosolids application and irrigation with reclaimed wastewater on transport of pharmaceutical compounds in arable soils. , 2013, Water research.
[16] D. Grandjean,et al. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. , 2005, Water research.
[17] K. Thomas,et al. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. , 2003, Journal of chromatography. A.
[18] M. Rubino,et al. Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms. , 2007, Chemosphere.
[19] Brett Paull,et al. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks. , 2009, The Analyst.
[20] Jeanne Garric,et al. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. , 2008, Toxicology letters.
[21] Michael Zwicky Hauschild. GM-troph: A Low Data Demand Ecotoxicity Effect Indicator for Use in LCIA (13+3 pp) , 2007 .
[22] Mark A J Huijbregts,et al. Transformation products in the life cycle impact assessment of chemicals. , 2010, Environmental science & technology.
[23] Xavier Gabarrell,et al. Accounting for the dissociating properties of organic chemicals in LCIA: an uncertainty analysis applied to micropollutants in the assessment of freshwater ecotoxicity. , 2013, Journal of hazardous materials.
[24] Antonio Franco,et al. Estimation of the soil–water partition coefficient normalized to organic carbon for ionizable organic chemicals , 2008, Environmental toxicology and chemistry.
[25] Peter W. Duenk,et al. Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field. , 2009, The Science of the total environment.
[26] D. Barceló,et al. Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro river basin (NE Spain). , 2012, The Science of the total environment.
[27] Max Maurer,et al. Elimination of β-blockers in sewage treatment plants , 2007 .
[28] M. Thomsen,et al. Ecotoxicological Quantitative Structure–Activity Relationships for Pharmaceuticals , 2007, Bulletin of environmental contamination and toxicology.
[29] J. S. Kang,et al. Increased phototoxicity of hydrochlorothiazide by photodegradation , 2000, Photodermatology, photoimmunology & photomedicine.
[30] Rolf Altenburger,et al. Phytotoxicity assessment of diclofenac and its phototransformation products , 2007, Analytical and bioanalytical chemistry.
[31] Yan-xin Wang,et al. Photodegradation of azithromycin in various aqueous systems under simulated and natural solar radiation: kinetics and identification of photoproducts. , 2011, Chemosphere.
[32] P. Verlicchi,et al. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review. , 2012, The Science of the total environment.
[33] J. Payet. Assessing toxic impacts on aquatic ecosystems in life cycle assessment (LCA) , 2004 .
[34] K. Fent,et al. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. , 2010, Aquatic toxicology.
[35] S. Mabury,et al. Aqueous photochemical reaction kinetics and transformations of fluoxetine. , 2005, Environmental science & technology.
[36] Michael Zwicky Hauschild. Evaluation of Ecotoxicity Effect Indicators for Use in LCIA (10+4 pp) , 2007 .
[37] Stig Irving Olsen,et al. Deliverable 4.2: Methodology for including specific biological effects and pathogen aspects into LCA , 2009 .
[38] Karin Treyer,et al. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. , 2011, Water research.
[39] G. Aherne,et al. The relevance of the presence of certain synthetic steroids in the aquatic environment , 1989, The Journal of pharmacy and pharmacology.
[40] A. Fernández-Alba,et al. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. , 2010, Water research.
[41] S. Canonica,et al. Phototransformation of Triclosan in Surface Waters: A Relevant Elimination Process for This Widely Used BiocideLaboratory Studies, Field Measurements, and Modeling , 2002 .
[42] Wenjing Fu,et al. Methods for estimating the bioconcentration factor of ionizable organic chemicals , 2009, Environmental toxicology and chemistry.
[43] Xuhua Xia,et al. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). , 2008, Physiological genomics.
[44] Mark A. J. Huijbregts,et al. USEtox—the UNEP-SETAC toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment , 2008 .
[45] W. Arnold,et al. Environmental photodegradation of mefenamic acid. , 2005, Chemosphere.
[46] Richard M. Dinsdale,et al. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.
[47] Roberto Andreozzi,et al. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. , 2003, Chemosphere.
[48] J. Payet,et al. Assessing Toxic Impacts on Aquatic Ecosystems in LCA , 2005 .
[49] A. Alder,et al. Fate of beta-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. , 2010, Water research.
[50] Anna-Karin Johansson,et al. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. , 2006, The Science of the total environment.
[51] K. Thomas,et al. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. , 2006, The Science of the total environment.
[52] B. Quinn,et al. The effects of pharmaceuticals on the regeneration of the cnidarian, Hydra attenuata. , 2008, The Science of the total environment.
[53] Damià Barceló,et al. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.
[54] P. Blánquez,et al. Multimedia fate modeling and comparative impact on freshwater ecosystems of pharmaceuticals from biosolids-amended soils. , 2013, Chemosphere.
[55] A. Fernández-Alba,et al. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. , 2007, Chemosphere.